General Biotechnology

Merck: Successor pill safer than Vioxx Merck & Co., the US drug maker that recalled its Vioxx painkiller because of […]

Big pharma’s pain could be biotech’s gain “Current problems besetting ‘big pharma’ could have a silver lining for the smaller

Big pharma’s pain could be biotech’s gain “Current problems besetting ‘big pharma’ could have a silver lining for the smaller

Few Americans Buy Meds Online “Few American adults have bought prescription drugs through the internet, despite rising drug costs and

The Waning Of The Blockbuster Drug “What’s promising now are drugs that target niche diseases. That means painful restructuring ahead

Financial Snapshot For September 2004 In Need Of A Boost

Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the

FDA Eases Rules on Drug Manufacturing “Drug makers will not need regulatory approval for every change in their manufacturing processes

Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company

Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company